Ask AI
CMV Antivirals
The Antiviral Angle: Leveraging the Full CMV Armamentarium

Released: August 21, 2025

Activity

Progress
1
Course Completed

Listen in as Dr Marcus Pereira discusses how to design cytomegalovirus (CMV) antiviral regimens for high-risk kidney transplant recipients to mitigate the impact of infection while minimizing drug toxicities. Topics include:

  • Strategies for CMV prevention: prophylaxis, preemptive therapy, and hybrid methods
  • Characteristics of available antiviral drugs
  • Monitoring considerations for antivirals